There have been some new updates to Integrated Shield Plans (hospital insurance) in Singapore you need to know about. The MediShield Life Council reported that spending on cancer drugs has been increasing by 20% a year; a stark contrast to the 6% spending increase for other drugs. To curb these rising costs, MOH has come up with a Cancer Drug List.
The Cancer Drug List contains drugs that are effective and cost-efficient drugs and treatments that insurance companies will cover. If the drug is effective but not cost-effective, insurance will not cover it. Not only this, even if the drug is very cheap, but does not improve the cancer treatment, insurers won’t cover.
Those with Integrated Shield Plans, will not allowed to be covered for treatment not on the list, even if they are still on treatment. Although this sounds very daunting, MOH has stated that close to 90% of current cancer drugs and treatment in Singapore are on this list.
While this isn’t ideal, and of course may affect many people, it does mean that your insurance premiums won’t skyrocket up and up each year. Medical inflation is already very high in Singapore; this is one way the government are stepping in to stop it from going out of hand.
But what does this mean for insurance moving forward? I would strongly suggest adding a cancer coverage to your portfolio, to cover the shortfall of possibly having to pay for a drug not on the Cancer Drug List. Receiving a lump-sum payment can help pay for monthly cancer drug expenses, which can be approximately $2,300 a month.
How do you think this affects you in Singapore?